Studies of Cytotoxicity Effects, SARS-CoV-2 Main Protease Inhibition, and in Silico Interactions of Synthetic Chalcones

被引:5
|
作者
Fernandes, Octavio L. Guterres L. [1 ]
Tizziani, Tiago [1 ]
Dambros, Bibiana P. [2 ]
de Sousa, Natalia Ferreira [3 ]
Pontes, Carime Mansur L. [1 ]
da Silva, Layzon A. L. [4 ]
Pollo, Luiz A. Escorteganha A. [4 ]
de Assis, Francisco F. [1 ]
Scotti, Marcus T. [3 ]
Scotti, Luciana [3 ]
Braga, Antonio L. [1 ]
Steindel, Mario [2 ]
Sandjo, Louis P. [1 ]
机构
[1] Univ Fed Santa Catarina, Dept Chem, Postgrad Program Chem, Campus Univ Trindade, BR-88040900 Florianopolis, SC, Brazil
[2] Univ Fed Santa Catarina, Dept Microbiol Immunol & Parasitol, BR-88040900 Florianopolis, SC, Brazil
[3] Univ Fed Paraiba, Dept Pharmaceut Sci, Postgrad Program Nat & Bioact Synthet Prod, BR-50670910 Joao Pessoa, Paraiba, Brazil
[4] Univ Fed Santa Catarina, Dept Pharmaceut Sci, Postgrad Program Pharm, Campus Univ Trindade, BR-88040900 Florianopolis, SC, Brazil
关键词
SARS-CoV-2; M-pro; inhibitory effects; heterocyclic chalcones; molecular docking; DERIVATIVES; COVALENT; VOLSURF; MOLDOCK;
D O I
10.1002/cbdv.202201151
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
SARS-CoV-2 main protease (M-pro) plays an essential role in proteolysis cleavage that promotes coronavirus replication. Thus, attenuating the activity of this enzyme represents a strategy to develop antiviral agents. We report inhibitory effects against M-pro of 40 synthetic chalcones, and cytotoxicity activities, hemolysis, and in silico interactions of active compounds. Seven of them bearing a (E)-3-(furan-2-yl)-1-arylprop-2-en-1-one skeleton (10, 28, and 35-39) showed enzyme inhibition with IC50 ranging from 13.76 and 36.13 mu M. Except for 35 and 36, other active compounds were not cytotoxic up to 150 mu M against THP-1 and Vero cell lines. Compounds 10, and 35-39 showed no hemolysis while 28 was weakly hemotoxic at 150 mu M. Moreover, molecular docking showed interactions between compound 10 and M-pro (PDBID 5RG2 and 5RG3) with proximity to cys145 and His41, suggesting a covalent binding. Products of the reaction between chalcones and cyclohexanethiol indicated that this binding could be a Michael addition type.
引用
收藏
页数:20
相关论文
共 50 条
  • [31] Acridone Alkaloids: In-Silico Investigation Against SARS-CoV-2 Main Protease
    Ogunyemi Olajide Oderinlo
    Chiamaka Gift Iwegbulam
    Overcomer Abumonye Ekweli
    Taye T. Alawode
    Oluwatoba Emmanuel Oyeneyin
    Chemistry Africa, 2022, 5 : 1441 - 1450
  • [32] In silico targeting SARS-CoV-2 spike protein and main protease by biochemical compounds
    Babaeekhou, Laleh
    Ghane, Maryam
    Abbas-Mohammadi, Mahdi
    BIOLOGIA, 2021, 76 (11) : 3547 - 3565
  • [33] In silico structure-based discovery of a SARS-CoV-2 main protease inhibitor
    Wen, Lei
    Tang, Kaiming
    Chik, Kenn Ka-Heng
    Chan, Chris Chun-Yiu
    Tsang, Jessica Oi-Ling
    Liang, Ronghui
    Cao, Jianli
    Huang, Yaoqiang
    Luo, Cuiting
    Cai, Jian-Piao
    Ye, Zi-Wei
    Yin, Feifei
    Chu, Hin
    Jin, Dong-Yan
    Yuen, Kwok-Yung
    Yuan, Shuofeng
    Chan, Jasper Fuk-Woo
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2021, 17 (06): : 1555 - 1564
  • [34] In silico evaluation of Philippine Natural Products against SARS-CoV-2 Main Protease
    Cheng, Adrian Josiah T.
    Macalino, Stephani Joy Y.
    Billones, Junie B.
    Balolong, Marilen Parungao
    Murao, Lyre Anni E.
    Carrillo, Maria Constancia O.
    JOURNAL OF MOLECULAR MODELING, 2022, 28 (11)
  • [35] In silico targeting SARS-CoV-2 spike protein and main protease by biochemical compounds
    Laleh Babaeekhou
    Maryam Ghane
    Mahdi Abbas-Mohammadi
    Biologia, 2021, 76 : 3547 - 3565
  • [36] Fragment-based in silico design of SARS-CoV-2 main protease inhibitors
    Ahmad, Sarfraz
    Mirza, Muhammad Usman
    Kee, Lee Yean
    Nazir, Mamoona
    Rahman, Noorsaadah Abdul
    Trant, John F.
    Abdullah, Iskandar
    CHEMICAL BIOLOGY & DRUG DESIGN, 2021, 98 (04) : 604 - 619
  • [37] Acridone Alkaloids: In-Silico Investigation Against SARS-CoV-2 Main Protease
    Oderinlo, Ogunyemi Olajide
    Iwegbulam, Chiamaka Gift
    Ekweli, Overcomer Abumonye
    Alawode, Taye T.
    Oyeneyin, Oluwatoba Emmanuel
    CHEMISTRY AFRICA-A JOURNAL OF THE TUNISIAN CHEMICAL SOCIETY, 2022, 5 (05): : 1441 - 1450
  • [38] In-silico drug repurposing for targeting SARS-CoV-2 main protease (Mpro)
    Sharma, Shilpa
    Deep, Shashank
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2022, 40 (07): : 3003 - 3010
  • [39] Identification of possible SARS-CoV-2 main protease inhibitors: in silico molecular docking and dynamic simulation studies
    Aniruddhya Mukherjee
    Khushhali Menaria Pandey
    Krishna Kumar Ojha
    Sumanta Kumar Sahu
    Beni-Suef University Journal of Basic and Applied Sciences, 12
  • [40] Identification of possible SARS-CoV-2 main protease inhibitors: in silico molecular docking and dynamic simulation studies
    Mukherjee, Aniruddhya
    Pandey, Khushhali Menaria
    Ojha, Krishna Kumar
    Sahu, Sumanta Kumar
    BENI-SUEF UNIVERSITY JOURNAL OF BASIC AND APPLIED SCIENCES, 2023, 12 (01)